U.S., Sept. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07156253) titled 'Study of SYN818 With Olaparib for the Treatment of Locally Advanced or Metastatic Solid Tum... Read More
U.S., Sept. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07156370) titled 'Salivary Cortisol and Hypercortisolism in Type 2 Diabetes' on Aug. 27. Brief Summary: The ... Read More
U.S., Sept. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07157462) titled 'Investigation of the Effects of a Multispecies Probiotic Formulation on Perennial Allergic ... Read More
U.S., Sept. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07156656) titled 'Sivelestat Treatment for Postoperative Organ Protection in Type A Aortic Dissection' on Aug... Read More
U.S., Sept. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07157969) titled 'PD-1 Inhibitors Combined With Targeted Therapy With or Without Interventional Therapy for A... Read More
U.S., Sept. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07157046) titled 'Association of Q Angle and Bunion Deformity of High Heel Wearing Females of Office Working ... Read More
U.S., Sept. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07157202) titled 'Associating Gastric Infection With Autoimmune Flare Severity in an Egyptians' on Aug. 28. ... Read More
U.S., Sept. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07156708) titled 'Aquatic Exercises Combined With Cognitive Tasks for Older Adults' on Aug. 26. Brief Summar... Read More
U.S., Sept. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07158515) titled 'The Heart Health After Cardiac Treatment Study' on Aug. 28. Brief Summary: The goal of thi... Read More
U.S., Sept. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07157306) titled 'Gecacitinib Combined With Donafenib and PD-1 Inhibitor as Immune Rechallenge Therapy for Un... Read More